Novel Flavonoid Derivatives Show Potent Efficacy in Human Lymphoma Models by Eugenio Gaudio, Paulina Biniecka, Alberto J. Arribas, Eleonora Cannas, Guido J. R. Zaman, Derya Unutmaz, Francesco Bertoni, Dan F. Stoicescu

Get full text

Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient by Johanne U. Hermansen, Paschalis Athanasiadis, Yanping Yin, Anne-Sofie F. Rise, Alberto J. Arribas, Luciano Cascione, Hege G. Russnes, Åslaug Helland, Anthony R. Mato, Francesco Bertoni, Geir E. Tjønnfjord, Tero Aittokallio, Sigrid S. Skånland

Get full text

Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies by Binu Kandathilparambil Sasi, Chiara Tarantelli, Stephen Martindale, Elisa Civanelli, Eleonora Cannas, Giulio Sartori, Alberto J. Arribas, Stacey M. Fernandes, Samantha J. Shupe, John-Hanson Machado, Svitlana Tyekucheva, Yue Ren, Michael Lahn, Lars van der Veen, Giusy Di Conza, Francesco Bertoni, Jennifer R. Brown

Get full text

PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas by Alberto J. Arribas, Sara Napoli, Eugenio Gaudio, Charles Herbaux, Eleonora Cannas, Chiara Tarantelli, Roberta Bordone-Pittau, Luciano Cascione, Nicolas Munz, Luca Aresu, Jacopo Sgrignani, Andrea Rinaldi, Ivo Kwee, Davide Rossi, Andrea Cavalli, Emanuele Zucca, Georg Stussi, Anastasios Stathis, Callum Sloss, Matthew S. Davids, Francesco Bertoni

Get full text